Latest News

Home testing devices could monitor epilepsy, drug levels, reduce clinical visits

Medications remain the mainstay of epilepsy treatment, and to date there are no FDA-approved devices that provide an accurate means of detection for generalized tonic-clonic seizures (GTCS), or convulsions, during activities of daily living. Two new studies provide data that warrants the development of non-invasive devices with the capability to signal the onset of an epileptic seizure and could be crucial to optimal patient dosing.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Death of a parent during childhood is associated with greater mortality in early adulthood

  • The 92 percent clean plate club: You're not alone in eating everything on your plate

  • Wide-faced men negotiate nearly ,200 larger signing bonus

  • How stress hormones promote brain's building of negative memories

  • Why do challenging tasks make consumers believe drugs wear off faster?

  • Empathy or justice: What makes consumers donate more to charity?

  • I?ll have what he's having? How consumers make choices about new products

  • Retail pricing strategies: Do consumers prefer Deep Discounts or Everyday Low Prices?

  • Clients of violence interventional advocacy program find experience supportive

  • Potential Genetic Link Between Epilepsy, Neurodegenerative Disorders

  •